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a b s t r a c t
INTRODUCTION:Rhabdomyosarcoma (RMS) is a primarymalignancy that arises from the embryonicmes-
enchyme with the potential to differentiate into skeletal muscle. RMS of the biliary tree is extremely rare.
We report a case of an undifferentiated pleomorphic RMS involving the liver and pancreas.
PRESENTATION OF CASE: A 62 year old Caucasian woman with rapidly growing abdominal mass and
a history of endometrial adenocarcinoma underwent laparotomy due to compression symptoms and
concerns ofmalignancy. A largemass arising from thepancreas andextending into the liverwas identiﬁed
and resected with a distal pancreatectomy associated with a left lateral liver segmentectomy. A diagnosis
of pleomorphic RMS was made from the pathology specimen. Chemotherapy and radiotherapy were also
performed. Unfortunately the patient died 2 years following treatment due to recurrence of the disease.
DISCUSSION: P-RMS in the biliary tree is extremely rare (0.5%) and mostly seen in infants and children.
Preoperative diagnosis is challenging since the symptoms are unspeciﬁc. Preoperative imaging rarely
contributes to the ﬁnal diagnosis. The only possible treatment for adult RMS is surgical resection of the
tumor followed by chemotherapy and radiotherapy. Long-term prognosis of P-RMS reported (predomi-
nantly of limbs) is poor. To our knowledge, no previous cases of RMS originating from the pancreas have
been reported.
CONCLUSION: However RMS is an extremely rare tumor in adults, it should be included in the differential
diagnosis of patients with atypical pancreatic and liver lesions.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Rhabdomyosarcoma (RMS) is a primary malignancy that arises
from the embryonic mesenchyme with the potential to differenti-
ate into skeletal muscle [1]. While it constitutes approximately 50%
of all soft tissue sarcomas in children, it is rare in adults accounting
for approximately 3% of all soft tissue sarcomas usually localized in
skeletalmuscle [2–4]. RMSwas described for the ﬁrst time byWeb-
ner in1854and later classiﬁed into fourhistopathological subtypes:
embryonal, botryoid, alveolar, and pleomorphic [1,4,5].
RMS of the biliary tree is extremely rare (approx. 0.5%) and
encountered mostly in infants and children [6] and it has been
described in four patients in relation to the gallbladder [7]. We
report a case of an undifferentiated pleomorphic RMS involving
the pancreas.
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2. Case presentation
A62year oldCaucasianwoman referred to our center for rapidly
growing epigastric mass. Her past medical history was signiﬁcant
for endometrial Cancer (Papillary Serous endometrial carcinoma,
Grade 1, FIGO IIb) two years prior treated by surgical resection
and radiotherapy. During the evaluation, an abdominal CT scan
revealed a large abdominal mass (11.5×9.4×12.1 cm) with irreg-
ular peripheral enhancement that appears to arise from left lobe of
the liver (Fig. 1A). It appeared compressing the portal vein and the
stomach. Ultrasound guided biopsy was performed and revealed
necrosis with rare degenerate atypical cells. Indications for surgical
intervention were concern of malignancy and compression symp-
toms. At surgery the mass had a capsular structure with numerous
vascular adhesions to the surrounding tissues (Fig. 1B). Left lat-
eral segmentectomy and distal pancreatectomy were performed
to remove the mass since macroscopically it appeared to invade
both organs (Fig. 1C and D). The patient recovered uneventfully.
At pathology the lesion measured (19×16.5×5.5 cm) with exten-
sive hemorrhage and necrosis. A ﬁne ﬁbrous septum separated the
tumor tissue fromtheadjacent liver andpancreasparenchymawith
an interruption only in the pancreas (Stage III, Group I according to
the International RMS Study Group; IRSG). Immunohistochemical
http://dx.doi.org/10.1016/j.ijscr.2015.05.029
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Fig. 1. (A) CT scan showing an 11.5×9.4×12.1 mass with irregular peripheral enhancement. (B and C): Epigastric mass on exploratory Laparotomy. (D) Mass resected
enblock with tail of the pancreas and the left lateral segment of the liver.
Fig. 2. (A) Pleomorphic rhabdomyosarcoma with haphazardly spindle cells and scattered cells with large eosinophilic cytoplasm and pleomorphic nuclei. (B) Elongated
rhabdomyoblasts with distinct cross striation and large eosinophilic stringy cytoplasm. (C) Neoplastic cells show reactivity for Desmin. (D) Neoplastic cells stained for
Myogenin.
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staining was positive for vimentin, desmin, myogen and SMA and
negative for cytokeratin AE1/AE3, EMA and S100 (Fig. 2). A deﬁni-
tive diagnosis of pleomorphic rhabdomyosarcoma (P-RMS) was
made. A chemotherapy regimen with cyclophosphamide, dactino-
mycin and vincristin started and continued for 4month. Alongwith
chemotherapy radiotherapy of the resection area was performed.
Patient was doing well for almost two years but she developed
symptoms of compression on the stomach such as fullness, nau-
sea and vomiting. Following further workup interval development
of a soft tissue lesion along the ventral surface of the pancreatic
head/neck,whichwas invading the adjacent gastricwallwere seen.
Findings were consistent with locoregional recurrence that was
conﬁrmed by tissue biopsy and was unresectable at this time, the
patient died 2 month later due to extent of the disease.
3. Discussion
In contrast to what has been described mostly for extremities of
adult males, P-RMS of the liver and pancreas represents an extraor-
dinary rare entity. P-RMS in the biliary tree is extremely rare (0.5%)
and mostly seen in infants and children [6]. There are only 2 cases
of P-RMS of the liver have been reported in the literature in adults
[8,9]. Ali et al. also reported a case of biliary RMSmimicking a chole-
dochal cyst [10]. We have no knowledge of any cases of P-RMS
arising from the pancreas in adults.
RMS arises from embryonic mesenchyme with the potential to
differentiate into skeletal muscle. Approximately half of all soft tis-
sue sarcomas in children are RMS while in adults are only 3% [4].
The origin of the tumor in our case appears to be pancreatic since
the interruption of the separating ﬁbrous tissue was seen only in
the pancreatic tissue and not in the liver.
Preoperative diagnosis is challenging since the symptoms are
unspeciﬁc with abdominal discomfort, weight loss and palpa-
ble abdominal mass. Preoperative imaging rarely contributes to
the ﬁnal diagnosis and shows a non-speciﬁc mass with periph-
eral enhancement. A preoperative biopsy is often non-diagnostic
because P-RMS requires special staining not routinely performed.
On pathologic examination polygonal large rhabdomyoblasts and
muscle speciﬁc markers for myogen, desmin, SMA and vimentin
are used to conﬁrm the diagnosis. The only possible treatment
for adult RMS is surgical resection of the tumor followed by
chemotherapy and radiotherapy. Data have shown that adult
RMS are chemo-sensitive tumors with response rates of about
75% [11,12]. The combination of vincristine, dactinomycin, and
cyclophosphamide has been established as the standard therapy in
patients with non-metastatic RMS [15]. Other combination thera-
pies have included ifosfamide and etoposide, although there have
been no improvement in outcome when ifosfamide was substi-
tuted for cyclophosphamide, or when etoposide and ifosfamide
were substituted for dactinomycin and cyclophosphamide. Multi-
variate analyses indicate that age, histologic subtype, primary site
location, stage, local control with surgery and/or radiation are sig-
niﬁcant predictors of survival in adults [13–16]. Age anddifferences
in distribution of histopathologic subtypes result in diminishing
chemosensitivity and lower tolerance for intensive therapy [17].
Disease that responded to chemotherapy was associated with a
better metastasis free interval [18]. A study by Ogilvie shows that
when combinedwith surgery and radiation therapy, chemotherapy
using doxorubicin, ifosfamide, and vincristine yielded 55% over-
all and 64% disease free survival at 2 years [11]. The study also
showed that patients with localized disease who achieve a patho-
logic response by neoadjuvant chemotherapy can become disease
free after surgery and radiation therapy. However, this study also
showed that patients with metastatic disease fail to achieve a
pathologic response due to other metastatic lesions not being
amendable to surgery. Long-term prognosis of P-RMS reported
(predominantly of limbs) is poor and survival rates vary from 12.5
to 50 % in the 1-year following treatment in adults [19]. In our case
the patient died 2 years following treatment due to recurrence of
the disease. Further studies are needed in the adult population to
establish an optimal therapy.
4. Conclusion
RMS is an extremely rare tumor in adults, but it should be
included in the list of differential diagnosis of patients presenting
with an atypical pancreatic or liver mass on imaging studies. Spe-
cial staining for RMS should also be considered for the abdominal
mass specimens to expedite the time to ﬁnal diagnosis and starting
the treatment.
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